Drug profile · INN
clesrovimab-cfor
ENFLONSIA
clesrovimab-cfor (ENFLONSIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: solution. Current US regulatory status: approved.
Drug details — clesrovimab-cfor
- US status
- approved
- Class
- —
- Route
- SOLUTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
clesrovimab-cfor (ENFLONSIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: solution. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is clesrovimab-cfor?
clesrovimab-cfor (ENFLONSIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: solution. Current US regulatory status: approved.
What is the brand name for clesrovimab-cfor?
ENFLONSIA is a marketed brand name for clesrovimab-cfor. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of clesrovimab-cfor?
clesrovimab-cfor has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.